Bernhard Hemmer

45.5k total citations · 3 hit papers
354 papers, 20.1k citations indexed

About

Bernhard Hemmer is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Bernhard Hemmer has authored 354 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Pathology and Forensic Medicine, 135 papers in Immunology and 87 papers in Neurology. Recurrent topics in Bernhard Hemmer's work include Multiple Sclerosis Research Studies (199 papers), Immunotherapy and Immune Responses (76 papers) and Peripheral Neuropathies and Disorders (58 papers). Bernhard Hemmer is often cited by papers focused on Multiple Sclerosis Research Studies (199 papers), Immunotherapy and Immune Responses (76 papers) and Peripheral Neuropathies and Disorders (58 papers). Bernhard Hemmer collaborates with scholars based in Germany, United States and United Kingdom. Bernhard Hemmer's co-authors include Sabine Cepok, Hans‐Peter Hartung, Thomas Korn, Roland Martinꝉ, Achim Berthele, Olaf Stüve, Stefan Nessler, Jeroen J.G. Geurts, Marco Vergelli and Olga Ciccarelli and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Bernhard Hemmer

344 papers receiving 19.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple sclerosis

2018 1.2k citations Bernhard Hemmer et al. profile →
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis

2011 927 citations Christian Gaser, Achim Berthele et al. profile →
Role of the innate and adaptive immune responses in the course of multiple sclerosis

2015 434 citations Bernhard Hemmer, Thomas Korn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Hemmer Germany	73	9.5k	6.9k	4.4k	3.8k	3.2k	354	20.1k
Stephen L. Hauser United States	70	8.4k 0.9×	5.9k 0.9×	2.8k 0.6×	3.6k 1.0×	2.4k 0.7×	275	16.9k
Amit Bar‐Or Canada	83	14.5k 1.5×	9.1k 1.3×	5.8k 1.3×	5.0k 1.3×	4.0k 1.2×	453	25.9k
Krzysztof Selmaj Poland	61	9.5k 1.0×	5.4k 0.8×	3.6k 0.8×	4.5k 1.2×	3.3k 1.0×	338	17.7k
Reinhard Hohlfeld Germany	82	10.0k 1.1×	7.6k 1.1×	6.0k 1.4×	5.6k 1.5×	3.2k 1.0×	301	23.0k
Emmanuelle Waubant United States	57	15.3k 1.6×	4.1k 0.6×	6.1k 1.4×	3.3k 0.9×	2.9k 0.9×	228	21.0k
Heinz Wiendl Germany	76	6.6k 0.7×	7.8k 1.1×	4.0k 0.9×	4.2k 1.1×	4.0k 1.3×	668	21.2k
Moses Rodriguez United States	79	13.7k 1.4×	6.5k 0.9×	6.1k 1.4×	5.4k 1.4×	2.9k 0.9×	489	27.0k
Jeffrey A. Cohen United States	69	13.2k 1.4×	2.6k 0.4×	5.6k 1.3×	4.1k 1.1×	3.1k 1.0×	314	22.7k
Scott S. Zamvil United States	58	5.1k 0.5×	8.0k 1.2×	2.0k 0.5×	3.4k 0.9×	2.3k 0.7×	191	15.4k
Michael Hutchinson Ireland	54	13.9k 1.5×	3.4k 0.5×	6.6k 1.5×	2.5k 0.7×	3.6k 1.1×	295	21.8k

Countries citing papers authored by Bernhard Hemmer

Since Specialization

Citations

This map shows the geographic impact of Bernhard Hemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Hemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Hemmer more than expected).

Fields of papers citing papers by Bernhard Hemmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Hemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Hemmer. The network helps show where Bernhard Hemmer may publish in the future.

Co-authorship network of co-authors of Bernhard Hemmer

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Hemmer. A scholar is included among the top collaborators of Bernhard Hemmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Hemmer. Bernhard Hemmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Würm, Reinhard, Robert Graf, Jan Valošek, et al.. (2025). Automatic segmentation of spinal cord lesions in MS: A robust tool for axial T2-weighted MRI scans. Imaging Neuroscience. 3. 1 indexed citations

Meineke, Jakob, Christine Preibisch, Sarah Schlaeger, et al.. (2025). Quantitative Susceptibility Mapping of Deep Grey Matter in MS: Association With Clinical Scores and Brain Volume Measures. Brain and Behavior. 15(10). e70988–e70988.

Held, Friederike, et al.. (2024). Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(1). e200322–e200322. 4 indexed citations

Kehl, Victoria, Arthur Wagner, Moritz Roman Hernández Petzsche, et al.. (2024). Functional Outcomes After Decompressive Surgery in Patients with Malignant Space-Occupying Cerebellar Infarction. Neurology International. 16(6). 1239–1246.

Wolf, Elisabeth, Lilian Aly, Christoph Schmaderer, et al.. (2024). Optical coherence tomography angiography suggests different retinal pathologies in multiple sclerosis and Sjögren’s syndrome. Journal of Neurology. 271(7). 4610–4619.

Tahedl, Marlene, Achim Berthele, Jan S. Kirschke, et al.. (2023). Cortical Thin Patch Fraction Reflects Disease Burden in MS: The Mosaic Approach. American Journal of Neuroradiology. 45(1). 82–89. 1 indexed citations

Aly, Lilian, Susanna Asseyer, Klemens Ruprecht, et al.. (2023). Retinal ganglion cell loss is associated with future disability worsening in early relapsing–remitting multiple sclerosis. European Journal of Neurology. 30(4). 982–990. 6 indexed citations

Otero‐Romero, Susana, Christine Lebrun‐Frénay, Saúl Reyes, et al.. (2023). European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. European Journal of Neurology. 30(8). 2144–2176. 6 indexed citations

Linnerbauer, Mathias, Tobias A. Beyer, Hania Kébir, et al.. (2023). PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nature Communications. 14(1). 5555–5555. 33 indexed citations

10.

Poeta, Maurizio Del, Brian J. Ward, Benjamin Greenberg, et al.. (2022). Cryptococcal Meningitis Reported With Fingolimod Treatment. Neurology Neuroimmunology & Neuroinflammation. 9(3). 17 indexed citations

11.

Hemmer, Bernhard, Bruce Cree, Benjamin Greenberg, et al.. (2021). COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients. Neurology Neuroimmunology & Neuroinflammation. 9(1). 25 indexed citations

12.

Tiemann, Laura, Matthias Bussas, Paul J. Schmidt, et al.. (2020). Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. Journal of Neurology. 267(8). 2307–2318. 29 indexed citations

13.

Aly, Lilian, Joachim Havla, Gildas Lepennetier, et al.. (2020). Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis. European Journal of Neurology. 27(11). 2217–2224. 22 indexed citations

14.

Schmidt, Paul J., Viola Pongratz, Pascal Küster, et al.. (2019). Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging. NeuroImage Clinical. 23. 101849–101849. 78 indexed citations

15.

Knier, Benjamin, Michael Hiltensperger, Christopher Sie, et al.. (2018). Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity. Nature Immunology. 19(12). 1341–1351. 81 indexed citations

16.

Montalbán, Xavier, Bernhard Hemmer, Kottil Rammohan, et al.. (2015). Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study. mediaTUM (Technical University of Munich). 36 indexed citations

17.

Rothhammer, Veit, Andreas Muschaweckh, Georg Gasteiger, et al.. (2014). α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets. Acta Neuropathologica Communications. 2(1). 27–27. 20 indexed citations

18.

Jordan, Denis, Rüdiger Ilg, Valentin Riedl, et al.. (2013). Simultaneous Electroencephalographic and Functional Magnetic Resonance Imaging Indicate Impaired Cortical Top–Down Processing in Association with Anesthetic-induced Unconsciousness. Anesthesiology. 119(5). 1031–1042. 137 indexed citations

19.

Kam-Thong, Tony, Darina Czamara, Koji Tsuda, et al.. (2010). EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units. European Journal of Human Genetics. 19(4). 465–471. 67 indexed citations

20.

Stüve, Olaf, Petra D. Cravens, Elliot M. Frohman, et al.. (2008). Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology. 72(5). 396–401. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact